Elsevier and Jisc sign three-year agreement to support transition to Open Access for UK Research

Elsevier(opens in new tab/window), a global leader in research publishing and information analytics, has signed a transitional agreement with Jisc – the negotiating body representing UK academic research institutions – to provide access to global research for UK readers, and to provide immediate open access to UK research for the world.

The three-year agreement meets the sector’s goals to rapidly transition to open access, at reduced costs relative to what the sector is paying today. The agreement reflects the start of a partnership and collaboration with Elsevier and UK institutions to deliver the largest agreement of its kind globally.

The agreement will enable authors at Jisc - UK institutions to publish immediate open access across all Elsevier journals. UK researchers will also be able to continue to read Elsevier’s extensive portfolio of journals. The agreement recognises the significant investment the UK has already made in its transition to open access over the last five years, and the challenges the UK higher education sector is facing.

Gemma Hersh, SVP Global Academic and Government Sales, Elsevier said: “Elsevier is proud to continue to support the UK’s world class research community. This agreement is a significant step towards a sustainable transition to immediate open access for UK research that supports authors in sharing their work and enables researchers to read the high quality, trusted research published in Elsevier journals. We appreciate the challenges the UK institutions face, especially because of the pandemic, and worked collaboratively with Jisc to create a tailored agreement which meets all the requirements set out on behalf of the sector.”

As one of the fastest-growing open access publishers in the world, nearly all of Elsevier's 2,700 journals enable open access publishing, including 600 fully open access journals. We now support over 2,000 institutions globally to publish open access through transformative agreements. In 2021 Elsevier published 119,000 gold or pay-to-publish open access articles, an increase of more than 46% over 2020.

For more on how Elsevier supports open access, please visit our website.

---

About Elsevier

As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, academic leaders, funders, R&D-intensive corporations, doctors, and nurses.  

Elsevier employs 9,000 people worldwide, including over 2,500 technologists. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect,  Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, medical education, and nursing education. Researchers and healthcare professionals rely on over 2,800 journals, including The Lancet(opens in new tab/window) and Cell(opens in new tab/window); 46,000+ eBook titles; and iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation(opens in new tab/window) and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. 

Elsevier is part of RELX(opens in new tab/window), a global provider of information-based analytics and decision tools for professional and business customers.